Susquehanna International Group, LLP Better Therapeutics, Inc. Call Options Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
Call Options
6 transactions
Others Institutions Holding BTTX
# of Institutions
1Shares Held
3KCall Options Held
0Put Options Held
0About Better Therapeutics, Inc.
- Ticker BTTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,743,000
- Description
- Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...